The open index of psychedelic research

Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification.

Kaadt E, Søkilde RF, Garling HD +5

Comparison of propofol and propofol-ketamine anesthesia on optic nerve sheath diameter in endovascular cerebral aneurysm procedures: a prospective randomized study.

Şahin E, Gökbulut Özaslan N, Erdem G +1

Psilocybin Precision Functional Mapping (data from Psilocybin desynchronizes the human brain)

Subramanian, S., Reneau, T.R., Perry, D. +1

'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.

Ham R, Gardner J, Carter A +1

Intravenous Ketamine reduces psychological pain in suicidal inpatients: A secondary analysis of a six-week randomized placebo-controlled trial.

Baryshnikov I, Demattei C, Abbar M +2

The impact of fluoxetine on the aversive effects of lysergic acid diethylamide.

Crupi R, Jimenez K, Sanel N +3

Discordant signals: How outcome measurement shapes interpretation of ketamine response in treatment-resistant depression.

Vazquez G, Kang MJY, Gutierrez G

Methodological Caveats in Evaluating Perioperative Esketamine for Postoperative Pain Sensitivity: A Comment on the Study by Chen et al [Letter].

Zhao S, Li J

Exploratory non-randomized clinical trial of subcutaneous esketamine in treatment-resistant depression: Effects of ketamine-assisted psychotherapy.

Varela YM, Cavalcanti-Ribeiro P, de Sousa GM +18

Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in healthy young adults

O’Shea A, Mason N, Schreiber R +4

Psilocybin acutely dissociates cognitive and affective empathy, with empathic concern predicting persisting positive psychological effects

Mason N, Mallaroni P, Kuypers K +4

Biomarker-Guided Antidepressant Selection

An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.

Kothiwala FM, Murphy RJ, Alshakhouri M +5

Hemodynamic and stress-modulating effects of adjuvant dexmedetomidine in esketamine-based anesthesia for laparoscopic hysterectomy: underappreciated neuroinflammatory regulation and unresolved long-term neurological safety issues.

Wang Z, Xie S

Propofol for depression: mechanisms and therapeutic potential.

Yu D, Liao Y, Li J +5

Psychedelic Use Covaries with Psychological Flexibility Through Mystical Experiences: Results of a Retrospective Web Survey.

Spata A, Sturges JW, Earleywine M

Sex-sensitive serotonergic signaling in psychedelic pharmacology.

Nasini S, Barzon B, Casile A +3

Circulating MicroRNAs and Their Associations with Neurotrophic, Inflammatory and Glutamate Markers in Healthy Volunteers

O’Shea A, Mason NL, Briede JJ +4

Neurobiological mechanisms underpinning chemsex: a scoping review of human neuroimaging and neurophysiological studies

Naulls S, Eccles J, Stone J

Severe Serotonin Syndrome With Acute Respiratory Failure Following Ayahuasca and Dextromethorphan Use: A Case Report.

Pack S, Ellett TR, Pham J +1

Ketamine Across the Dose-State Continuum: EEG Signatures, Network Dynamics, and Implications for Brain-State Monitoring in Anesthesia and Critical Care.

Chauhan V, Khan F

QTAIM-analysis

Flores, Anaid, SORIANO, LUIS ANTONIO, Lazcano Carrasco, Imelda Lizeth +3

Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.

Dean JG, Hurwitz E, Furnish T +16

Microdosing psychedelics: What, why, when, and how often? Insights from an international survey of people who use psychedelics.

Petranker R, Syed OA, Sobolenko V +5